Dealflow | March 22, 2018

Wellthy Therapeutics raises $2.1M for chronic disease care

The team at


The Mumbai-based digital health startup has developed a smartphone app to help patients learn about and manage chronic diseases, including diabetes.

Early results from its diabetes pilot have reportedly shown that a majority of patients using the app are able to better regulate their blood sugar levels.

Chronic diseases like diabetes are responsible for the highest number of deaths in India and are the biggest cost burden on the country’s healthcare system.

The company raised a seed round from family office Manipal Education and Medical Group, Beenext Ventures, GrowX Ventures, Currae Healthcare and several individuals.